Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy
- PMID: 24360503
- DOI: 10.1016/j.neurobiolaging.2013.11.019
Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy
Abstract
Neurodegenerative diseases, such as Alzheimer's disease Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, share a common cellular and molecular pathogenetic mechanism involving aberrant misfolded protein or peptide aggregation and deposition. Autophagy represents a major route for degradation of aggregated cellular proteins and dysfunctional organelles. Emerging studies have demonstrated that up-regulation of autophagy can lead to decreased levels of these toxic aggregate-prone proteins, and is beneficial in the context of aging and various models of neurodegenerative diseases. Understanding the signaling pathways involved in the regulation of autophagy is crucial to the development of strategies for therapy. This review will discuss the cellular and molecular mechanisms of autophagy and its important role in the pathogenesis of aging and neurodegenerative diseases, and the ongoing drug discovery strategies for therapeutic modulation.
Keywords: Aging; Alzheimer's disease; Amyotrophic lateral sclerosis; Autophagy; Huntington's disease; Lysosomal storage disorders; Parkinson's disease; Therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.Biochem Soc Trans. 2013 Oct;41(5):1103-30. doi: 10.1042/BST20130134. Biochem Soc Trans. 2013. PMID: 24059496
-
Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives.J Neurochem. 2011 Aug;118(3):317-25. doi: 10.1111/j.1471-4159.2011.07314.x. Epub 2011 Jun 17. J Neurochem. 2011. PMID: 21599666 Review.
-
Autophagy and apoptosis dysfunction in neurodegenerative disorders.Prog Neurobiol. 2014 Jan;112:24-49. doi: 10.1016/j.pneurobio.2013.10.004. Epub 2013 Nov 6. Prog Neurobiol. 2014. PMID: 24211851 Review.
-
Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.Curr Top Dev Biol. 2006;76:89-101. doi: 10.1016/S0070-2153(06)76003-3. Curr Top Dev Biol. 2006. PMID: 17118264 Review.
-
Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases.Ageing Res Rev. 2017 Nov;40:64-74. doi: 10.1016/j.arr.2017.09.005. Epub 2017 Sep 18. Ageing Res Rev. 2017. PMID: 28923312 Review.
Cited by
-
Peroxisomal Pex3 activates selective autophagy of peroxisomes via interaction with the pexophagy receptor Atg30.J Biol Chem. 2015 Mar 27;290(13):8623-31. doi: 10.1074/jbc.M114.619338. Epub 2015 Feb 18. J Biol Chem. 2015. PMID: 25694426 Free PMC article.
-
CTB-targeted protocells enhance ability of lanthionine ketenamine analogs to induce autophagy in motor neuron-like cells.Sci Rep. 2023 Feb 13;13(1):2581. doi: 10.1038/s41598-023-29437-8. Sci Rep. 2023. PMID: 36781993 Free PMC article.
-
The tricyclic antidepressant clomipramine inhibits neuronal autophagic flux.Sci Rep. 2019 Mar 19;9(1):4881. doi: 10.1038/s41598-019-40887-x. Sci Rep. 2019. PMID: 30890728 Free PMC article.
-
Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy.Cell Death Dis. 2020 May 21;11(5):385. doi: 10.1038/s41419-020-2594-x. Cell Death Dis. 2020. PMID: 32439839 Free PMC article.
-
Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.Neurotox Res. 2018 Oct;34(3):733-748. doi: 10.1007/s12640-018-9895-1. Epub 2018 Apr 7. Neurotox Res. 2018. PMID: 29626319 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical